Home » Topics » Regulatory » Patents

Patents
RSS

Cytokine inhibitors in development at Sumitomo for AIDS and other disorders

Feb. 5, 1999

Modulators of nAChR a focus of research at NeuroSearch

Feb. 5, 1999

New Celgene compounds reduceTNF-alpha levels and NF-kB activity

Feb. 5, 1999

1,6-Naphthyridine anticonvulsants in research at SmithKline Beecham

Feb. 4, 1999

Preparation and use of nAChR modulators disclosed by NeuroSearch

Feb. 4, 1999

Roche patents novel compounds interacting with group II mGluR

Feb. 4, 1999

New GABA-A receptor ligands for anxiety, convulsions

Feb. 4, 1999

Production and use of KSHVIL-6/vMIP-1alpha II peptides, antibodies and antisense oligonucleotides

Feb. 4, 1999

N- and L-type calcium channel inhibitors developed by Ajinomoto

Feb. 4, 1999

Bayer describes production and use of 2,9-disubstituted purin-6-ones

Feb. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...